Recall of Ibuprofen and Oxcarbazepine TabletsDue to Mislabeled Packaging
AUGUST 27, 2014
Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall - Mislabeled Packaging
Please check your ibuprofen and your Oxcarbazepine today! You could be gettting ibuprofen instead of Oxcarbazepine and visa versa! American Health Packaging (AHP) voluntarily recalled Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a hospital unit dose presentation that may contain individual blistered doses labeled as Oxcarbazepine Tablets, 300 mg, lot #142544. In addition, AHP voluntarily recalled Oxcarbazepine Tablets, 300 mg, lot #142544, Expiration Date, 02/2016. This recall is the result of mislabeled inner unit dose blister packaging which could result in patients receiving ibuprofen and missing their scheduled dose of oxcarbazepine. For more information please check out the FDA website at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm406124.htm or talk with your doctor to determine if you might be affected.
Read our Archived Updates for more information on past questions and answers.
Want to know more about the exciting research going on at the Kennedy Krieger Institute to discover new therapies for Sturge-Weber syndrome?
Visit our Current Research section.
Institute Discovers the Cause of Sturge-Weber
To learn more about our recent discovery View our press coverage
Dr. Comi's Updates
Dr. Comi announces research findings, posts important information, and answers questions of general interest to families living with Sturge-Weber syndrome.
Sturge-Weber Center News
Sturge-Weber Center Events
Tropical Realty Charity Golf Tournament
NOVEMBER 15, 2016
Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.